These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30546094)

  • 1. The role of the microbiota in infectious diseases.
    Libertucci J; Young VB
    Nat Microbiol; 2019 Jan; 4(1):35-45. PubMed ID: 30546094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of fermented milk products, prebiotics and probiotics on microbiota composition and health.
    Ceapa C; Wopereis H; Rezaïki L; Kleerebezem M; Knol J; Oozeer R
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):139-55. PubMed ID: 23768559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Summary of the 8
    De Lorenzi-Tognon M; Genton L; Schrenzel J
    Rev Med Suisse; 2023 Jun; 19(830):1149-1153. PubMed ID: 37283386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Human Microbiota, Infectious Disease, and Global Health: Challenges and Opportunities.
    Waldman AJ; Balskus EP
    ACS Infect Dis; 2018 Jan; 4(1):14-26. PubMed ID: 29207239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
    Koopman N; Molinaro A; Nieuwdorp M; Holleboom AG
    Aliment Pharmacol Ther; 2019 Sep; 50(6):628-639. PubMed ID: 31373710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Microbiome: What Will the Future Hold?
    Monsour HP; Quigley EM
    Semin Liver Dis; 2016 Sep; 36(4):354-359. PubMed ID: 27997976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of prebiotics and probiotics in prevention and treatment of childhood infectious diseases.
    Weichert S; Schroten H; Adam R
    Pediatr Infect Dis J; 2012 Aug; 31(8):859-62. PubMed ID: 22801095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics and prebiotics in infectious gastroenteritis.
    Vandenplas Y
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):49-53. PubMed ID: 27048896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the gut microbiota, prebiotics, and probiotics on human health and disease.
    Lin CS; Chang CJ; Lu CC; Martel J; Ojcius DM; Ko YF; Young JD; Lai HC
    Biomed J; 2014; 37(5):259-68. PubMed ID: 25179725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial modulation of the gut microbiota.
    Walsh CJ; Guinane CM; O'Toole PW; Cotter PD
    FEBS Lett; 2014 Nov; 588(22):4120-30. PubMed ID: 24681100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of the Gut Microbiota in the Prevention and Treatment of Sepsis.
    Haak BW; Prescott HC; Wiersinga WJ
    Front Immunol; 2018; 9():2042. PubMed ID: 30250472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic modulation of microbiota-host metabolic interactions.
    Holmes E; Kinross J; Gibson GR; Burcelin R; Jia W; Pettersson S; Nicholson JK
    Sci Transl Med; 2012 Jun; 4(137):137rv6. PubMed ID: 22674556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Dysbiosis for the Treatment of Liver Disease.
    Anand G; Zarrinpar A; Loomba R
    Semin Liver Dis; 2016 Feb; 36(1):37-47. PubMed ID: 26870931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human intestinal microbiota and healthy ageing.
    Tiihonen K; Ouwehand AC; Rautonen N
    Ageing Res Rev; 2010 Apr; 9(2):107-16. PubMed ID: 19874918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugging the gut microbiota: toward rational modulation of bacterial composition in the gut.
    Altamura F; Maurice CF; Castagner B
    Curr Opin Chem Biol; 2020 Jun; 56():10-15. PubMed ID: 31678829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BOARD INVITED REVIEW: The pig microbiota and the potential for harnessing the power of the microbiome to improve growth and health1.
    Aluthge ND; Van Sambeek DM; Carney-Hinkle EE; Li YS; Fernando SC; Burkey TE
    J Anim Sci; 2019 Sep; 97(9):3741-3757. PubMed ID: 31250899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.